First-in-Man Use of the Percutaneous 10F Reitan Catheter Pump for Cardiorenal Syndrome
- PMID: 35649225
- DOI: 10.1097/MAT.0000000000001498
First-in-Man Use of the Percutaneous 10F Reitan Catheter Pump for Cardiorenal Syndrome
Abstract
Cardiorenal syndrome worsens outcome in patients with decompensated chronic heart failure, and complicates recompensation by medical therapy. Mechanical circulatory support has the potential to improve renal function, and likely mitigates diuretic resistance in patients with severe cardiorenal syndrome. The Reitan catheter pump (RCP) is a novel temporary percutaneous circulatory support system for reducing cardiac afterload and increasing renal preload. Here, we report on the first-in-man use of the 10F-version of the RCP device, which was associated with favorable effects on hemodynamics and diuresis. Further investigation to evaluate safety and efficacy of this promising approach is warranted.
Copyright © ASAIO 2021.
References
-
- Keeble TR, Karamasis GV, Rothman MT, et al.: Percutaneous haemodynamic and renal support in patients presenting with decompensated heart failure: A multi-centre efficacy study using the Reitan Catheter Pump (RCP). Int J Cardiol. 275: 53–58, 2019.
-
- Regamey J, Barras N, Rusca M, Hullin R: A role for the Reitan catheter pump for percutaneous cardiac circulatory support of patients presenting acute congestive heart failure with low output and renal dysfunction? Future Cardiol. 16: 159–164, 2020.
-
- German Registry for Clinical Studies. Available at: https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRI... . Accessed March 12, 2020.
-
- Chahal RS, Chukwu CA, Kalra PR, Kalra PA: Heart failure and acute renal dysfunction in the cardiorenal syndrome. Clin Med (Lond). 20: 146–150, 2020.
-
- Schefold JC, Filippatos G, Hasenfuss G, Anker SD, von Haehling S: Heart failure and kidney dysfunction: Epidemiology, mechanisms and management. Nat Rev Nephrol. 12: 610–623, 2016.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical